Detection of the novel IL-1 family cytokines by QAH-IL1F-1 assay in rheumatoid arthritis

Cellular and Molecular Biology

Volumn 62, Issue 4, 2016, Pages 31-34

  Wang, M ^a,b   Wang, B ^b   Ma, Z ^b   Sun, X ^b   Tang, Y ^b   Li, X ^b   Wu, Xiudi ^c  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c NINGBO NO 2 HOSPITAL   (China)

Author keywords

IL 1 family cytokines; QAH IL1F 1 assay; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN M; INTERLEUKIIN 36GAMMA; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 36ALPHA; INTERLEUKIN 36BETA; INTERLEUKIN 36RA; INTERLEUKIN 37; INTERLEUKIN 38; UNCLASSIFIED DRUG; CYTOKINE; INTERLEUKIN 36, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNOASSAY; MALE; PATHOGENESIS; RHEUMATOID ARTHRITIS; BLOOD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PROCEDURES;

ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN M; INTERLEUKIN-1; MALE; MIDDLE AGED;

EID: 84994881401     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.14715/cmb/2016.62.4.6     Document Type: Article

References (32)

1. Feldmann M and Maini SR Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunological Reviews, 2008, 223(1):7-19.
2. Miao J, Zhang K, Lv M, Li Q, Zheng Z, Han Q, Guo N, Fan C, Zhu P. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis, Scand J Rheumatol, 2014, 43(3):194-201.
3. Niu X and Chen G. Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis, J Immunol Res 2014, 698192.
4. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol, 2009, 27:519-550.
5. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol, 2002, 20:S1-13.
6. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL and Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1998, 31:315-324.
7. Olsen NJ and Stein CM. New drugs for rheumatoid arthritis. The New England Journal of Medicine, 2004, 350(21):2167-2226.
8. Bansard C, Lequerre T, Derambure C, Vittecoq Q, Hiron M, Daragon A, Pouplin S, Daveau M, Boyer Q, Tron F, Le Loet X and Salier JP. Gene profiling predicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra). Rheumatology, 2011, 50(2):283-292.
9. Smolen JS, Aletaha D, Koeller M, Weisman MH and Emery P. New therapies for treatment of rheumatoid arthritis. The Lancet, 2007, 370(9602):1861-1874.
10. Meyer PW, Hodkinson B, Ally M, Musenge E, Wadee AA, Fickl H, Tikly M and Anderson R. Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis. Mediators Inflamm, 2010, 2010:158514.
11. Deane KD, O'Donnell CI, Hueber W, Majka DS, Lazar AA, Derber LA, Gilliland WR, Edison JD, Norris JM, Robinson WH and Holers VM. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum, 2010, 62(11):3161-3172.
12. Sims JE and Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol, 2010, 10:89-102.
13. Smith DE, Renshaw BR, Ketchem RR, Kubin M, Garka KE and Sims JE. Four new members expand the interleukin-1 superfamily. J. Biol. Chem, 2000, 275:1169-1175.
14. Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ and Preshaw PM. Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin. Exp. Immunol, 2009, 156:479-487.
15. Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, Rodriguez E, Ronchi F, Sallusto F, Dinh H, Sims JE and Gabay C. IL-36R ligands are potent regulators of dendritic and T cells. Blood, 2011, 118: 5813-5823.
16. Li Y, Messina C, Bendaoud M, Fine DH, Schreiner H, Tsiagbe VK. Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol. Oral Microbiol, 2010, 25: 275-292.
17. Carrier Y, Ma H.L, Ramon H.E, Napierata L, Small C, O'Toole M, Young D.A, Fouser L.A, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K, Medley QG. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: Implications in psoriasis pathogenesis. J. Investig. Dermatol, 2011, 131, 2428-2437.
18. Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, Rodriguez E, Ronchi F, Sallusto F, Dinh H, Sims J.E, Gabay C. IL-36R ligands are potent regulators of dendritic and T cells. Blood, 2011, 118, 5813-5823.
19. Frey S, Derer A, Messbacher ME, Baeten DL, Bugatti S, Montecucco C, Schett G and Hueber AJ. The novel cytokine interleukin-36a is expressed in psoriatic and rheumatoid arthritis synovium. Ann Rheum Dis, 2013, 72:1569-1574.
20. Magne D, Palmer G, Barton JL, Mezin F, Talabot-Ayer D, Bas S, Duffy T, Noger M, Gueme PA, Nicklin MJ and Gabay C. The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes. Arthritis Res Ther, 2006, 8(3):R80.
21. Chu M, Wong CK, Cai Z, Dong J, Jiao D, Kam NW, Lam CW and Tam LS. Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus. Molecules, 2015, 20:19588-19604.
22. van de Veerdonk FL, Stoeckman AK, Wu G, Boeckermann AN, Azam T, Netea MG, Joosten LA, van der Meer JW, Hao R, Kalabokis V and Dinarello CA. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(8): 3001-3005.
23. Lin H, Ho AS, Haley-Vicente D, Zhang J, Bernal-Fussell J, Pace AM, Hansen D, Schweighofer K, Mize NK and Ford JE. Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J. Biol. Chem, 2001, 276:20597-20602.
24. Rahman P, Sun S, Peddle L, Snelgrove T, Melay W, Greenwood C and Gladman D. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis and Rheumatism, 2006, 54(7):2321-2325.
25. Chou CT, Timms AE, Wei JC, Tsai WC, Wordsworth BP and Brown MA. Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese. Annals of the Rheumatic Diseases, 2006, 65(8):1106-1109.
26. Guo ZS, Li C, Lin ZM, Huang JX, Wei QJ, Wang XW, Xie YY, Liao ZT, Chao SY and Gu JR. Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population. International Journal of Immunogenetics, 2010, 37(1):33-37.
27. Bufler P, Azam T, Gamboni-Robertson F, Reznikov LL, Kumar S, Dinarello CA and Kim SH. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci USA, 2002, 99:13723-13728.
28. Zhao PW, Jiang WG, Wang L, Jiang ZY, Shan YX and Jiang YF. Plasma levels of IL-37 and correlation with TNF-alpaha, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PloS One, 2014, 9:e95346.
29. Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, Pitman N, Kurowska-Stolarska M, Mckenzie AN, Mclnnes IB and Liew FY. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA, 2008, 105:10913-10918.
30. Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S, Finckh A, Smith DE and Gabay C. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum, 2009, 60:738-749.
31. Yeon-Sik Hong, Su-Jin Moon, Young-Bin Joo, Chan-Hong Jeon, Mi-La Cho, Ji Hyeon Ju, Hye-Jwa Oh, Yu-Jung Heo, Sung-Hwan Park, Ho-Youn Kim and Jun-Ki Min. Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis. Immunology, Allergic Disorders & Rheumatology, 2011, 26: 1132-1139.
32. Waldiceu A Verri Jr, Fabrício O Souto, Silvio M Vieira, Sergio C L Almeida, Sandra Y Fukada, Damo Xu, Jose C Alves-Filho, Thiago M Cunha, Ana T G Guerrero, Rafaela B Mattos-Guimaraes, Fabíola R Oliveira, Mauro M Teixeira, João S Silva, Iain B McInnes, Sergio H Ferreira, Paulo Louzada-Junior, Foo Y Liew, Fernando Q Cunha. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis, 2010, 69:1697-1703.